François Haguinet

1.7k total citations
28 papers, 862 citations indexed

About

François Haguinet is a scholar working on Epidemiology, Infectious Diseases and Toxicology. According to data from OpenAlex, François Haguinet has authored 28 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 8 papers in Infectious Diseases and 8 papers in Toxicology. Recurrent topics in François Haguinet's work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (9 papers) and Pharmacovigilance and Adverse Drug Reactions (8 papers). François Haguinet is often cited by papers focused on Influenza Virus Research Studies (14 papers), Respiratory viral infections research (9 papers) and Pharmacovigilance and Adverse Drug Reactions (8 papers). François Haguinet collaborates with scholars based in Belgium, United Kingdom and United States. François Haguinet's co-authors include Roger Lustig, Robert J. Taylor, Gonçalo Matias, Cynthia Schuck‐Paim, Vivek Shinde, Douglas Fleming, John Logie, David J. Webb, Sylvia Taylor and Germano Ferreira and has published in prestigious journals such as BMC Public Health, Vaccine and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

François Haguinet

28 papers receiving 843 citations

Peers

Countries citing papers authored by François Haguinet

Since Specialization

Citations

This map shows the geographic impact of François Haguinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Haguinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Haguinet more than expected).

Fields of papers citing papers by François Haguinet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Haguinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Haguinet. The network helps show where François Haguinet may publish in the future.

Co-authorship network of co-authors of François Haguinet

This figure shows the co-authorship network connecting the top 25 collaborators of François Haguinet. A scholar is included among the top collaborators of François Haguinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Haguinet. François Haguinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tree‐temporal scan statistics for safety signal detection in vaccine clinical trials 2024 ·Pharmaceutical Statistics ·François Haguinet, Fabián Tibaldi, (unknown), Andrew Bate	1
2	Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data 2023 ·Drug Safety ·(unknown), Israa Mahmoud, François Haguinet, Andrew Bate, Maurizio Sessa	5
3	Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing 2023 ·Drug Safety ·(unknown), Andrew Bate, François Haguinet, Gabriel Westman, (unknown), Anders Hviid, Maurizio Sessa	9
4	Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk 2023 ·Drug Safety ·Olivia Mahaux, (unknown), François Haguinet, (unknown), (unknown), (unknown), (unknown), Andrew Bate	5
5	MSR20 NLP and Machine Learning to Automate Identification of Suspected Medication Errors from Real World Unstructured Narratives 2023 ·Value in Health ·Jeffery L. Painter, François Haguinet, (unknown), Andrew Bate	1
6	ADVANCE system testing: Estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data 2020 ·Vaccine ·Caitlin Dodd, Maria de Ridder, Daniel Weibel, Olivia Mahaux, François Haguinet, Tom De Smedt, Simon de Lusignan, (unknown), Talita Duarte‐Salles, Hanne‐Dorthe Emborg, Consuelo Huerta, Elisa Martín‐Merino, Gino Picelli, Klára Berencsi, (unknown), Miriam Sturkenboom	2
7	Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study 2019 ·JMIR Public Health and Surveillance ·Simon de Lusignan, Ana Correa, Gaël Dos Santos, Nadia Meyer, François Haguinet, Rebecca Webb, Christopher McGee, Rachel Byford, Ivelina Yonova, Sameera Pathirannehelage, Filipa Ferreira, Simon Jones	11
8	ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination 2019 ·Vaccine ·Daniel Weibel, Caitlin Dodd, Olivia Mahaux, François Haguinet, Tom De Smedt, Talita Duarte‐Salles, Gino Picelli, Lara Tramontan, (unknown), Ana Correa, (unknown), Elisa Martín‐Merino, Consuelo Huerta, Klára Berencsi, Hanne‐Dorthe Emborg, Kaatje Bollaerts, Vincent Bauchau, Lina Titievsky, Miriam Sturkenboom	8
9	Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000–2012 2018 ·BMJ Open ·Emad Yanni, Germano Ferreira, (unknown), (unknown), (unknown), François Haguinet, Emmanuelle Espié, Véronique Bianco	55
10	Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England 2017 ·BMJ Open ·Simon de Lusignan, Gaël Dos Santos, Ana Correa, François Haguinet, Ivelina Yonova, (unknown), Rachel Byford, Filipa Ferreira, (unknown), Tom Chan	8
11	Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view 2017 ·Vaccine ·Catherine Cohet, Dominique Rosillon, Corinne Willame, François Haguinet, (unknown), (unknown), (unknown), Vincent Bauchau, Laurence Baril	7
12	Estimates of hospitalization attributable to influenza and RSV in the US during 1997–2009, by age and risk status 2017 ·BMC Public Health ·Gonçalo Matias, Robert J. Taylor, François Haguinet, Cynthia Schuck‐Paim, Roger Lustig, Vivek Shinde	100
13	Model estimates of the burden of outpatient visits attributable to influenza in the United States 2016 ·BMC Infectious Diseases ·Gonçalo Matias, François Haguinet, Roger Lustig, Laurel Edelman, Gerardo Chowell, Robert J. Taylor	27
14	Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series 2016 ·BMJ Open ·Catherine Cohet, François Haguinet, Gaël Dos Santos, (unknown), John Logie, Germano Ferreira, Dominique Rosillon, Vivek Shinde	23
15	Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK 2016 ·BMJ Open ·Sylvia Taylor, Robert J. Taylor, Roger Lustig, Cynthia Schuck‐Paim, François Haguinet, David J. Webb, John Logie, Gonçalo Matias, Douglas Fleming	73
16	Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series 2016 ·Vaccine ·Gaël Dos Santos, François Haguinet, Catherine Cohet, (unknown), John Logie, Germano Ferreira, Dominique Rosillon, Vivek Shinde	21
17	Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom 2016 ·BMC Public Health ·Gonçalo Matias, Robert J. Taylor, François Haguinet, Cynthia Schuck‐Paim, Roger Lustig, Douglas Fleming	71
18	Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015 2015 ·Eurosurveillance ·Shelly McNeil, Melissa K. Andrew, (unknown), François Haguinet, Todd F. Hatchette, May ElSherif, Jason J. LeBlanc, (unknown), Allison McGeer, Janet E. McElhaney, Mark Loeb, Donna MacKinnon‐Cameron, (unknown), Gaël Dos Santos, (unknown)	35
19	The epidemiology of herpes zoster and its complications in Medicare cancer patients 2015 ·BMC Infectious Diseases ·(unknown), Adrienne Guignard, François Haguinet, Ann S. LaCasce, Arthur T. Skarin, (unknown), (unknown), Mei Sheng Duh	35
20	Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study 2013 ·BMJ Open ·Irwin Nazareth, Fernanda Tavares Da Silva, Dominique Rosillon, François Haguinet, Vincent Bauchau	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact